Journal
CHEMISTRY-A EUROPEAN JOURNAL
Volume 12, Issue 14, Pages 3741-3753Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/chem.200500923
Keywords
antitumor agents; molecular modeling; NMR spectroscopy; olignucleotides; platinum
Categories
Ask authors/readers for more resources
The cytotoxic, pyrazolato-bridged dinuclear platinum(ii) complex [(cis-{Pt(NH3)(2)})(2)(mu-OH)(mu-pz)](2+) (pz=pyrazolate) has been found to cross-link two adjacent guanines of a double-stranded DNA decamer without destabilizing the duplex and without changing the directionality of the helix axis. A H-1 NMR study of the oligonucleotide d(CTCTG*G*TCTC)-d(GAGACCAGAG), cross-linked at the two G* guanines by [(cis-{Pt-(NH3)(2)})(2)(mu-pz)](3+), and molecular dynamics simulations of the explicitly solvated duplex were performed to characterize the structural details of the adduct. The dinuclear platinum cross-link unwinds the helix by approximately 15 degrees, that is, to a similar extent as the widely used antitumor drug cisplatin, but, in contrast to the latter, induces no significant bend in the helix axis. The Watson-Crick base-pairing remains intact, and the melting temperature of the duplex is unaffected by the crosslink. ne helical twist is considerably reduced between the two platinated bases, as becomes manifest in an unusually short sequential H1'-H1' distance. This unwinding also affects the sugar ring of the guanosine in the 3'-position to the cross-link, which presents an N reversible arrow S equilibrium. This is the first cytotoxic platinum complex that has been successfully designed by envisioning the structural consequences of its binding to DNA.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available